Shares of Senomyx Inc. (NASDAQ:SNMX) fell 1.6% during trading on Tuesday . The stock traded as low as $2.41 and last traded at $2.48, with a volume of 107,450 shares. The stock had previously closed at $2.52.

Separately, Zacks Investment Research raised Senomyx from a “sell” rating to a “hold” rating in a report on Thursday, April 14th.

The company’s 50 day moving average is $2.96 and its 200 day moving average is $2.92. The firm’s market cap is $114.14 million.

Senomyx (NASDAQ:SNMX) last announced its quarterly earnings results on Thursday, April 28th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.03. The business had revenue of $6.30 million for the quarter, compared to analysts’ expectations of $5.78 million. The firm’s quarterly revenue was up 26.0% on a year-over-year basis. During the same period last year, the firm earned ($0.11) earnings per share. On average, equities research analysts anticipate that Senomyx Inc. will post ($0.25) EPS for the current year.

An institutional investor recently raised its position in Senomyx stock. Turner Investments L.P. raised its position in Senomyx Inc. (NASDAQ:SNMX) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 345,000 shares of the company’s stock after buying an additional 33,000 shares during the period. Turner Investments L.P. owned about 0.78% of Senomyx worth $1,301,000 at the end of the most recent quarter.

Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.